It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
GNGBY’s FA Score shows that 2 FA rating(s) are green whileSNN’s FA Score has 1 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
GNGBY’s TA Score shows that 3 TA indicator(s) are bullish while SNN’s TA Score has 4 bullish TA indicator(s).
GNGBY (@Medical/Nursing Services) experienced а -4.21% price change this week, while SNN (@Medical/Nursing Services) price change was -3.88% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -2.11%. For the same industry, the average monthly price growth was +2.65%, and the average quarterly price growth was +8.69%.
SNN is expected to report earnings on Nov 06, 2025.
The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
GNGBY | SNN | GNGBY / SNN | |
Capitalization | 5.78B | 15.2B | 38% |
EBITDA | 5.51B | 1.33B | 414% |
Gain YTD | 40.823 | 46.483 | 88% |
P/E Ratio | 36.87 | 31.74 | 116% |
Revenue | 35.5B | 5.94B | 597% |
Total Cash | 1.95B | 676M | 288% |
Total Debt | 11.2B | 3.45B | 324% |
GNGBY | SNN | ||
---|---|---|---|
OUTLOOK RATING 1..100 | 71 | 62 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 14 Undervalued | 15 Undervalued | |
PROFIT vs RISK RATING 1..100 | 94 | 100 | |
SMR RATING 1..100 | 85 | 94 | |
PRICE GROWTH RATING 1..100 | 50 | 47 | |
P/E GROWTH RATING 1..100 | 14 | 81 | |
SEASONALITY SCORE 1..100 | 50 | 75 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
GNGBY's Valuation (14) in the null industry is in the same range as SNN (15) in the Medical Specialties industry. This means that GNGBY’s stock grew similarly to SNN’s over the last 12 months.
GNGBY's Profit vs Risk Rating (94) in the null industry is in the same range as SNN (100) in the Medical Specialties industry. This means that GNGBY’s stock grew similarly to SNN’s over the last 12 months.
GNGBY's SMR Rating (85) in the null industry is in the same range as SNN (94) in the Medical Specialties industry. This means that GNGBY’s stock grew similarly to SNN’s over the last 12 months.
SNN's Price Growth Rating (47) in the Medical Specialties industry is in the same range as GNGBY (50) in the null industry. This means that SNN’s stock grew similarly to GNGBY’s over the last 12 months.
GNGBY's P/E Growth Rating (14) in the null industry is significantly better than the same rating for SNN (81) in the Medical Specialties industry. This means that GNGBY’s stock grew significantly faster than SNN’s over the last 12 months.
GNGBY | SNN | |
---|---|---|
RSI ODDS (%) | 2 days ago57% | 2 days ago52% |
Stochastic ODDS (%) | 2 days ago49% | 2 days ago59% |
Momentum ODDS (%) | 2 days ago60% | 2 days ago59% |
MACD ODDS (%) | 2 days ago53% | 2 days ago43% |
TrendWeek ODDS (%) | 2 days ago57% | 2 days ago58% |
TrendMonth ODDS (%) | 2 days ago55% | 2 days ago61% |
Advances ODDS (%) | 4 days ago67% | 18 days ago57% |
Declines ODDS (%) | 2 days ago58% | 2 days ago58% |
BollingerBands ODDS (%) | 2 days ago65% | 2 days ago41% |
Aroon ODDS (%) | 2 days ago65% | 2 days ago60% |
A.I.dvisor tells us that GNGBY and CNMD have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GNGBY and CNMD's prices will move in lockstep.
Ticker / NAME | Correlation To GNGBY | 1D Price Change % | ||
---|---|---|---|---|
GNGBY | 100% | +1.61% | ||
CNMD - GNGBY | 32% Poorly correlated | +0.02% | ||
ALGN - GNGBY | 29% Poorly correlated | +1.05% | ||
AVNS - GNGBY | 28% Poorly correlated | +1.90% | ||
SNN - GNGBY | 27% Poorly correlated | +0.40% | ||
AEMD - GNGBY | 26% Poorly correlated | -2.24% | ||
More |
A.I.dvisor indicates that over the last year, SNN has been loosely correlated with STAA. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if SNN jumps, then STAA could also see price increases.
Ticker / NAME | Correlation To SNN | 1D Price Change % | ||
---|---|---|---|---|
SNN | 100% | +0.40% | ||
STAA - SNN | 42% Loosely correlated | +0.19% | ||
SYK - SNN | 42% Loosely correlated | +0.12% | ||
ALC - SNN | 39% Loosely correlated | +0.93% | ||
TFX - SNN | 38% Loosely correlated | +2.56% | ||
OFIX - SNN | 38% Loosely correlated | -0.63% | ||
More |